All the information you need about ELFE PHARMA to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-06-28 | Public | 2021-12-31 | Complete |
| 2021-06-08 | Public | 2020-12-31 | Complete |
| 2020-05-27 | Public | 2019-12-31 | Complete |
| 2019-09-20 | Public | 2018-12-31 | Complete |
| 2018-07-09 | Public | 2017-12-31 | Complete |
| 2017-07-18 | Public | 2016-12-31 | Complete |
| Name | ELFE PHARMA |
| Siren | 794516088 |
| Closing | 2020-12-31 |
| Registry code | 8701 |
| Registration number | 3061 |
| Management number | 2013B00656 |
| Activity code | 6420Z |
| Closing date n-1 | 2019-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2021-06-08 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 87220 FEYTIAT |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
BJ TOTAL (I) | 1 750 304.00 | 1 750 304.00 | 1 750 304.00 | |
BZ Other receivables | 8 021.00 | 8 021.00 | 8 021.00 | |
CF Cash and cash equivalents | 8 716.00 | 8 716.00 | 8 716.00 | |
CJ TOTAL (II) | 16 737.00 | 16 737.00 | 16 737.00 | |
CO Grand total (0 to V) | 1 767 042.00 | 1 767 042.00 | 1 767 042.00 | |
CU Other investments | 1 750 304.00 | 1 750 304.00 | 1 750 304.00 | |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 5 000.00 | 5 000.00 | 5 000.00 | |
DD Legal reserve (1) | 500.00 | 500.00 | 500.00 | |
DG Other reserves | 529 442.00 | 480 296.00 | 529 442.00 | |
DH Retained earnings | 252 923.00 | 252 923.00 | 252 923.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | 220 456.00 | 149 146.00 | 220 456.00 | |
DL TOTAL (I) | 1 008 322.00 | 887 866.00 | 1 008 322.00 | |
DU Loans and Debts from Credit Institutions (3) | 601 648.00 | 657 179.00 | 601 648.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 155 670.00 | 215 348.00 | 155 670.00 | |
DX Trade payables and related accounts | 1 400.00 | 1 200.00 | 1 400.00 | |
DY Tax and social security liabilities | 15 385.00 | |||
EC TOTAL (IV) | 758 719.00 | 889 112.00 | 758 719.00 | |
EE Grand total (I to V) | 1 767 042.00 | 1 776 978.00 | 1 767 042.00 | |
EG Accrued income and payables due within one year | 260 330.00 | 333 889.00 | 260 330.00 | |
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FW Other purchases and external expenses | 2 237.00 | |||
GF Total Operating Expenses (II) | 2 237.00 | |||
GG - OPERATING RESULT (I - II) | -2 237.00 | |||
GJ Financial income from other securities and fixed asset receivables | 229 200.00 | |||
GP Total financial income (V) | 229 200.00 | |||
GR Interest and similar expenses | 8 404.00 | |||
GU Total financial expenses (VI) | 8 404.00 | |||
GV - FINANCIAL INCOME (V - VI) | 220 795.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | 218 558.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HK Income tax | -1 898.00 | -2 144.00 | -1 898.00 | |
HL TOTAL REVENUE (I + III + V + VII) | 229 200.00 | 158 400.00 | 229 200.00 | |
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) | 8 744.00 | 9 254.00 | 8 744.00 | |
HN PROFIT OR LOSS (Total revenue - Total expenses) | 220 456.00 | 149 146.00 | 220 456.00 | |
